FDA Oncology

Exploring pharmacogenetic testing for DPD deficiency – FDA Oncology

FDA Oncology posted on X:

“FDA Oncology Center’s Jennifer Gao and AACR President Patricia M. LoRusso will moderate an FDA-AACR workshop Jan. 16 exploring the considerations surrounding pharmacogenetic testing for dihydropyrimidine dehydrogenase (DPD) deficiency.

Register now.”

AACR cancer DPD deficiency FDA Oncology Jennifer Gao OncoDaily Oncology Patricia M. LoRusso